Skip to main content
Top
Published in: BMC Infectious Diseases 1/2016

Open Access 01-12-2016 | Research article

The prevalence of ESBL-producing Enterobacteriaceae in a nursing home setting compared with elderly living at home: a cross-sectional comparison

Authors: Andreas Blom, Jonas Ahl, Fredrik Månsson, Fredrik Resman, Johan Tham

Published in: BMC Infectious Diseases | Issue 1/2016

Login to get access

Abstract

Background

The aim of the study was to investigate the prevalence of faecal carriage of extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae among residents living in nursing homes and to compare it with a corresponding group of elderly people living in their own homes.

Methods

A total of 160 persons participated in the study between February and April 2014, 91 were residents in nursing homes (n = 10) and the remaining 69 were elderly living in their own homes. In addition to performing faecal samples, all participants answered a standardized questionnaire regarding known risk factors for ESBL-carriage.

Results

There was no significant difference between the groups, as 10 of the 91 (11 %) residents from nursing homes were ESBL-carriers compared with 6 of 69 (8,7 %) elderly living in their own homes. There was no significant difference between the groups. The total prevalence was 10 %. A univariate analysis revealed that the only studied risk factor significantly associated with ESBL-carriage was recent foreign travel (p = 0,017). All ESBL-positive isolates were Escherichia coli and there was a high degree of co-resistance to other antibiotics. All isolates (n = 17) were susceptible to imipenem and amikacin.

Conclusion

Residents of nursing homes as well as elderly living in their own homes have high rates of faecal carriage of ESBL-producing bacteria. These findings may affect the choice of empirical antibiotic treatment of severe infections in older adults.
Literature
1.
go back to reference Pitout JD, Laupland KB. Extended-spectrum beta-lactamase-producing enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis. 2008;8(3):159–66.CrossRefPubMed Pitout JD, Laupland KB. Extended-spectrum beta-lactamase-producing enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis. 2008;8(3):159–66.CrossRefPubMed
2.
go back to reference Ben-Ami R, Rodriguez-Bano J, Arslan H, Pitout JD, Quentin C, Calbo ES, et al. A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients. Clin infect dis : an official publication of the Infectious Diseases Society of America. 2009;49(5):682–90.CrossRef Ben-Ami R, Rodriguez-Bano J, Arslan H, Pitout JD, Quentin C, Calbo ES, et al. A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients. Clin infect dis : an official publication of the Infectious Diseases Society of America. 2009;49(5):682–90.CrossRef
3.
go back to reference Colodner R, Rock W, Chazan B, Keller N, Guy N, Sakran W, et al. Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients. Eur j clin microbiolinfectdis : official publication of the European Society of Clinical Microbiology. 2004;23(3):163–7.CrossRef Colodner R, Rock W, Chazan B, Keller N, Guy N, Sakran W, et al. Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients. Eur j clin microbiolinfectdis : official publication of the European Society of Clinical Microbiology. 2004;23(3):163–7.CrossRef
4.
go back to reference Pitout JD. Infections with extended-spectrum beta-lactamase-producing enterobacteriaceae: changing epidemiology and drug treatment choices. Drugs. 2010;70(3):313–33.CrossRefPubMed Pitout JD. Infections with extended-spectrum beta-lactamase-producing enterobacteriaceae: changing epidemiology and drug treatment choices. Drugs. 2010;70(3):313–33.CrossRefPubMed
5.
go back to reference Tangden T, Cars O, Melhus A, Lowdin E. Foreign travel is a major risk factor for colonization with escherichia coli producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with swedish volunteers. Antimicrob Agents Chemother. 2010;54(9):3564–8.CrossRefPubMedPubMedCentral Tangden T, Cars O, Melhus A, Lowdin E. Foreign travel is a major risk factor for colonization with escherichia coli producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with swedish volunteers. Antimicrob Agents Chemother. 2010;54(9):3564–8.CrossRefPubMedPubMedCentral
6.
go back to reference Tham J, Odenholt I, Walder M, Andersson L, Melander E. Risk factors for infections with extended-spectrum beta-lactamase-producing escherichia coli in a county of Southern Sweden. Infection and drug resistance. 2013;6:93–7.CrossRefPubMedPubMedCentral Tham J, Odenholt I, Walder M, Andersson L, Melander E. Risk factors for infections with extended-spectrum beta-lactamase-producing escherichia coli in a county of Southern Sweden. Infection and drug resistance. 2013;6:93–7.CrossRefPubMedPubMedCentral
7.
go back to reference Tham J, Odenholt I, Walder M, Brolund A, Ahl J, Melander E. Extended-spectrum beta-lactamase-producing escherichia coli in patients with travellers' diarrhoea. Scand J Infect Dis. 2010;42(4):275–80.CrossRefPubMed Tham J, Odenholt I, Walder M, Brolund A, Ahl J, Melander E. Extended-spectrum beta-lactamase-producing escherichia coli in patients with travellers' diarrhoea. Scand J Infect Dis. 2010;42(4):275–80.CrossRefPubMed
8.
go back to reference Gruber I, Heudorf U, Werner G, Pfeifer Y, Imirzalioglu C, Ackermann H, et al. Multidrug-resistant bacteria in geriatric clinics, nursing homes, and ambulant care—prevalence and risk factors. Intj med microbiol: IJMM. 2013;303(8):405–9.CrossRef Gruber I, Heudorf U, Werner G, Pfeifer Y, Imirzalioglu C, Ackermann H, et al. Multidrug-resistant bacteria in geriatric clinics, nursing homes, and ambulant care—prevalence and risk factors. Intj med microbiol: IJMM. 2013;303(8):405–9.CrossRef
9.
go back to reference Stuart RL, Kotsanas D, Webb B, Vandergraaf S, Gillespie EE, Hogg GG, et al. Prevalence of antimicrobial-resistant organisms in residential aged care facilities. Med J Aust. 2011;195(9):530–3.CrossRefPubMed Stuart RL, Kotsanas D, Webb B, Vandergraaf S, Gillespie EE, Hogg GG, et al. Prevalence of antimicrobial-resistant organisms in residential aged care facilities. Med J Aust. 2011;195(9):530–3.CrossRefPubMed
10.
go back to reference Brolund A, Edquist PJ, Makitalo B, Olsson-Liljequist B, Soderblom T, Wisell KT, et al. Epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli in Sweden 2007–2011. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2014;20(6):O344–52. Brolund A, Edquist PJ, Makitalo B, Olsson-Liljequist B, Soderblom T, Wisell KT, et al. Epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli in Sweden 2007–2011. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2014;20(6):O344–52.
13.
go back to reference Stromdahl H, Tham J, Melander E, Walder M, Edquist PJ, Odenholt I. Prevalence of faecal ESBL carriage in the community and in a hospital setting in a county of Southern Sweden. Eur j clin microbiol infect dis : official publication of the European Society of Clinical Microbiology. 2011;30(10):1159–62.CrossRef Stromdahl H, Tham J, Melander E, Walder M, Edquist PJ, Odenholt I. Prevalence of faecal ESBL carriage in the community and in a hospital setting in a county of Southern Sweden. Eur j clin microbiol infect dis : official publication of the European Society of Clinical Microbiology. 2011;30(10):1159–62.CrossRef
14.
go back to reference Chabok A, Tarnberg M, Smedh K, Pahlman L, Nilsson LE, Lindberg C, et al. Prevalence of fecal carriage of antibiotic-resistant bacteria in patients with acute surgical abdominal infections. Scand J Gastroenterol. 2010;45(10):1203–10.CrossRefPubMed Chabok A, Tarnberg M, Smedh K, Pahlman L, Nilsson LE, Lindberg C, et al. Prevalence of fecal carriage of antibiotic-resistant bacteria in patients with acute surgical abdominal infections. Scand J Gastroenterol. 2010;45(10):1203–10.CrossRefPubMed
15.
go back to reference Andersson H, Lindholm C, Iversen A, Giske CG, Ortqvist A, Kalin M, et al. Prevalence of antibiotic-resistant bacteria in residents of nursing homes in a swedish municipality: healthcare staff knowledge of and adherence to principles of basic infection prevention. Scand J Infect Dis. 2012;44(9):641–9.CrossRefPubMed Andersson H, Lindholm C, Iversen A, Giske CG, Ortqvist A, Kalin M, et al. Prevalence of antibiotic-resistant bacteria in residents of nursing homes in a swedish municipality: healthcare staff knowledge of and adherence to principles of basic infection prevention. Scand J Infect Dis. 2012;44(9):641–9.CrossRefPubMed
16.
go back to reference Jans B, Schoevaerdts D, Huang TD, Berhin C, Latour K, Bogaerts P, et al. Epidemiology of multidrug-resistant microorganisms among nursing home residents in Belgium. PLoS One. 2013;8(5), e64908.CrossRefPubMedPubMedCentral Jans B, Schoevaerdts D, Huang TD, Berhin C, Latour K, Bogaerts P, et al. Epidemiology of multidrug-resistant microorganisms among nursing home residents in Belgium. PLoS One. 2013;8(5), e64908.CrossRefPubMedPubMedCentral
17.
go back to reference Rooney PJ, O'Leary MC, Loughrey AC, McCalmont M, Smyth B, Donaghy P, et al. Nursing homes as a reservoir of extended-spectrum beta-lactamase (ESBL)-producing ciprofloxacin-resistant escherichia coli. J Antimicrob Chemother. 2009;64(3):635–41.CrossRefPubMed Rooney PJ, O'Leary MC, Loughrey AC, McCalmont M, Smyth B, Donaghy P, et al. Nursing homes as a reservoir of extended-spectrum beta-lactamase (ESBL)-producing ciprofloxacin-resistant escherichia coli. J Antimicrob Chemother. 2009;64(3):635–41.CrossRefPubMed
18.
go back to reference Giske CG, Monnet DL, Cars O, Carmeli Y. Clinical and economic impact of common multidrug-resistant gram-negative bacilli. Antimicrob Agents Chemother. 2008;52(3):813–21.CrossRefPubMed Giske CG, Monnet DL, Cars O, Carmeli Y. Clinical and economic impact of common multidrug-resistant gram-negative bacilli. Antimicrob Agents Chemother. 2008;52(3):813–21.CrossRefPubMed
19.
go back to reference Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO. Extended-spectrum beta-lactamase-producing escherichia coli and klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin infect dis : an official publication of the Infectious Diseases Society of America. 2001;32(8):1162–71.CrossRef Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO. Extended-spectrum beta-lactamase-producing escherichia coli and klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin infect dis : an official publication of the Infectious Diseases Society of America. 2001;32(8):1162–71.CrossRef
20.
go back to reference Melzer M, Petersen I. Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing E. Coli compared to non-ESBL producing E. Coli. J Infect. 2007;55(3):254–9.CrossRefPubMed Melzer M, Petersen I. Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing E. Coli compared to non-ESBL producing E. Coli. J Infect. 2007;55(3):254–9.CrossRefPubMed
21.
go back to reference Schwaber MJ, Carmeli Y. Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J Antimicrob Chemother. 2007;60(5):913–20.CrossRefPubMed Schwaber MJ, Carmeli Y. Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J Antimicrob Chemother. 2007;60(5):913–20.CrossRefPubMed
22.
go back to reference Valverde A, Grill F, Coque TM, Pintado V, Baquero F, Canton R, et al. High rate of intestinal colonization with extended-spectrum-beta-lactamase-producing organisms in household contacts of infected community patients. J Clin Microbiol. 2008;46(8):2796–9.CrossRefPubMedPubMedCentral Valverde A, Grill F, Coque TM, Pintado V, Baquero F, Canton R, et al. High rate of intestinal colonization with extended-spectrum-beta-lactamase-producing organisms in household contacts of infected community patients. J Clin Microbiol. 2008;46(8):2796–9.CrossRefPubMedPubMedCentral
23.
go back to reference Oteo J, Perez-Vazquez M, Campos J. Extended-spectrum [beta]-lactamase producing escherichia coli: changing epidemiology and clinical impact. Curr Opin Infect Dis. 2010;23(4):320–6.CrossRefPubMed Oteo J, Perez-Vazquez M, Campos J. Extended-spectrum [beta]-lactamase producing escherichia coli: changing epidemiology and clinical impact. Curr Opin Infect Dis. 2010;23(4):320–6.CrossRefPubMed
24.
go back to reference Woerther PL, Burdet C, Chachaty E, Andremont A. Trends in human fecal carriage of extended-spectrum beta-lactamases in the community: toward the globalization of CTX-M. Clin Microbiol Rev. 2013;26(4):744–58.CrossRefPubMedPubMedCentral Woerther PL, Burdet C, Chachaty E, Andremont A. Trends in human fecal carriage of extended-spectrum beta-lactamases in the community: toward the globalization of CTX-M. Clin Microbiol Rev. 2013;26(4):744–58.CrossRefPubMedPubMedCentral
25.
go back to reference Hilty M, Betsch BY, Bogli-Stuber K, Heiniger N, Stadler M, Kuffer M, et al. Transmission dynamics of extended-spectrum beta-lactamase-producing enterobacteriaceae in the tertiary care hospital and the household setting. Clin infect dis : an official publication of the Infectious Diseases Society of America. 2012;55(7):967–75.CrossRef Hilty M, Betsch BY, Bogli-Stuber K, Heiniger N, Stadler M, Kuffer M, et al. Transmission dynamics of extended-spectrum beta-lactamase-producing enterobacteriaceae in the tertiary care hospital and the household setting. Clin infect dis : an official publication of the Infectious Diseases Society of America. 2012;55(7):967–75.CrossRef
26.
go back to reference Rodriguez-Bano J, Lopez-Cerero L, Navarro MD, Diaz de Alba P, Pascual A. Faecal carriage of extended-spectrum beta-lactamase-producing escherichia coli: prevalence, risk factors and molecular epidemiology. J Antimicrob Chemother. 2008;62(5):1142–9.CrossRefPubMed Rodriguez-Bano J, Lopez-Cerero L, Navarro MD, Diaz de Alba P, Pascual A. Faecal carriage of extended-spectrum beta-lactamase-producing escherichia coli: prevalence, risk factors and molecular epidemiology. J Antimicrob Chemother. 2008;62(5):1142–9.CrossRefPubMed
27.
go back to reference Van Aken S, Lund N, Ahl J, Odenholt I, Tham J. Risk factors, outcome and impact of empirical antimicrobial treatment in extended-spectrum beta-lactamase-producing escherichia coli bacteraemia. Scand J Infect Dis. 2014;46(11):753–62.CrossRefPubMed Van Aken S, Lund N, Ahl J, Odenholt I, Tham J. Risk factors, outcome and impact of empirical antimicrobial treatment in extended-spectrum beta-lactamase-producing escherichia coli bacteraemia. Scand J Infect Dis. 2014;46(11):753–62.CrossRefPubMed
29.
go back to reference Donaldson H, McCalmont M, Livermore DM, Rooney PJ, Ong G, McHenry E, et al. Evaluation of the VITEK 2 AST N-054 test card for the detection of extended-spectrum beta-lactamase production in escherichia coli with CTX-M phenotypes. J Antimicrob Chemother. 2008;62(5):1015–7.CrossRefPubMed Donaldson H, McCalmont M, Livermore DM, Rooney PJ, Ong G, McHenry E, et al. Evaluation of the VITEK 2 AST N-054 test card for the detection of extended-spectrum beta-lactamase production in escherichia coli with CTX-M phenotypes. J Antimicrob Chemother. 2008;62(5):1015–7.CrossRefPubMed
Metadata
Title
The prevalence of ESBL-producing Enterobacteriaceae in a nursing home setting compared with elderly living at home: a cross-sectional comparison
Authors
Andreas Blom
Jonas Ahl
Fredrik Månsson
Fredrik Resman
Johan Tham
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2016
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-016-1430-5

Other articles of this Issue 1/2016

BMC Infectious Diseases 1/2016 Go to the issue